View Cart ()
Your cart is empty
There’s a difference between asking for history—and testing it.
Invitae helps you test your patients’ past, so you can improve their future.
Request more info
The time for genetic testing is now.
Integrating germline genetic testing into your standard of care for patients at risk for or with active prostate cancer can help you:
Determine
which patients may benefit from PSA screening at an earlier age
Evaluate
the timing for tumor biopsy and/or diagnosis
Reveal
patients in need of more immediate intervention compared to those who can proceed with active surveillance
Identify
patients eligible for new treatments and/or more frequent surveillance
Test
family members of patients who may also be at increased risk
Curious about when to use genetic testing?
Pre-diagnosis
PSA testing, while useful to screen for prostate cancer, may leave you and your patients with more questions than answers.
That’s where genetic testing comes in.
Integrating germline genetic testing with PSA testing can help identify patients who may have a genetic predisposition to prostate cancer.
Additionally, genetic testing may help you determine whether or not a tumor biopsy is needed.
That helps limit invasive interventions and prevent potential complications.
Post-diagnosis
Patients under active surveillance may require frequent office visits, screenings, or changes to their treatment regimen.
With genetic testing, you can use results to risk stratify those with more aggressive disease progression and:
Identify patients in need of more urgent care. Some with particular genetic mutations may benefit from radiation or surgical intervention to reduce the risk of metastasis, improving prognosis and quality of life.
Discern patients eligible for new treatments. PARP inhibitors recently received FDA approval for the treatment of BRCA- or HRR-mutated mCRPC after previous therapies have failed.
Tailor screening measures. Establish how often a patient requires screening, or discover the need for additional cancer screenings, such as pancreatic cancer.
Why Invitae?
Invitae makes genetic testing simple.
